FDA
approval
· 2022-04-04
FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Sandoz Inc)
Summary
FDA approves Sandoz Inc's original ANDA for a fixed-dose combination of brimonidine tartrate and timolol maleate to lower intraocular pressure in adults with op…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE (BRIMONIDINE TARTRATE AND TIMOLOL MALEATE)